Tyler Binney News Today

/PRNewswire/ -- Intrinsic Therapeutics, Inc., the developer of the Barricaid, an FDA approved medical device proven to significantly reduce reherniations and...

Slated to close in the first quarter of 2024, the deal could include “additional contingent payments” based on Relievant’s sales.

Relievant Medsystems released the Intracept Simulator System, a training program for the Intracept procedure, the company said Sept. 21.

Relievant Medsystems announced today that it released its Intracept simulator system, a training platform for the Intracept procedure.

Boston Scientific (NYSE:BSX) announced today that it entered into a definitive agreement to acquire Relievant Medsystems.

/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., a...

Relievant Medsystems announced four-year pooled data from two prospective clinical trials that support the use of its Intracept procedure.

MIAMI, July 14, 2023 (GLOBE NEWSWIRE) — ASPN Annual Conference – Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of…

Relievant Medsystems announced today that it launched its next-generation access instruments for the Intracept procedure.

Relievant Medsystems says three-year data from two clinical trials further validate its Intracept procedure to treat chronic back pain.